News
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
4d
Zacks Investment Research on MSNFDA Grants Accelerated Approval to Regeneron's Blood Cancer DrugRegeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness ...
FDA updates CAR T-cell therapy labels, easing monitoring requirements and expanding access for eligible patients in oncology.
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
FDA approval could also lead more employers and schools to issue vaccine mandates. On May 7, Pfizer and BioNTech became the first companies to apply for approval for their two-shot mRNA vaccine; ...
U.K. study: HPV vaccine reduced cervical cancer rates by 87% in women who were vaccinated at 12 and 13 03:48. The maker of an at-home cervical cancer screening test said Friday it has won approval ...
Wildtype’s salmon is not the first lab-grown food to receive the FDA’s stamp of approval—that honor went to two companies’ cultured chicken in 2022—but this does mark the first time a ...
The FDA approved three new natural food color additives — galdieria extract, butterfly pea flower extract, and calcium phosphate — to replace synthetic petroleum-based dyes.
The FDA approved three natural food dyes that comes from plants and minerals this week, amid its transition away from petroleum-based dyes in the food supply.
The FDA approved three natural food dyes that comes from plants and minerals this week, amid its transition away from petroleum-based dyes in the food supply.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results